Matinas BioPharma Holdings, Inc. (MTNB) AMEX
0.61
-0.0276(-4.33%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.61
-0.0276(-4.33%)
Currency In USD
| Market Cap | 2.48M |
| Enterprise Value | -1.91M |
| P/E Ratio | -0.19 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.51 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.03 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.8 |
| Return On Equity | -2.5 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -19.19M |
| Net Income | -24.25M |
| Diluted EPS | -4.98 |
| Total Cash | 5.44M |
| Total Cash/Share | 1 |
| Total Debt | 2.33M |
| Total Debt/Equity | 0.36 |
| Current Ratio | 3.78 |
| Book Value Per Share | 1.19 |
| 52-Week Change | 12.96 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.48 |
| Moving Average 50 Days | 0.63 |
| Moving Average 200 Days | 1.09 |
| Average Volume | 30,261 |
| Shares Outstanding | 5.55M |
| % Held by Institutions | 8.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | September 03, 2024 |